Ezurpimtrostat
- Generic Name
- Ezurpimtrostat
- Drug Type
- Small Molecule
- Chemical Formula
- C25H31ClN4
- CAS Number
- 1914148-72-3
- Unique Ingredient Identifier
- MS6LGW5JFK
Ezurpimtrostat Autophagy Inhibitor in Association With Atezolizumab-Bevacizumab in First Line Treatment of Unresectable Hepatocellular Carcinoma
Phase 2
Terminated
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2022-07-07
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- University Hospital, Grenoble
- Target Recruit Count
- 3
- Registration Number
- NCT05448677
- Locations
- π«π·
University Hospital, Grenoble, France
A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection
- First Posted Date
- 2020-11-20
- Last Posted Date
- 2021-07-28
- Lead Sponsor
- Genoscience Pharma
- Target Recruit Count
- 178
- Registration Number
- NCT04637828
- Locations
- π«π·
Genoscience Pharma, Marseille, France
Study of GNS561 in Patients With Liver Cancer
Phase 1
Terminated
- Conditions
- Hepatocellular CarcinomaCholangiocarcinoma, Intrahepatic
- Interventions
- First Posted Date
- 2017-10-20
- Last Posted Date
- 2022-05-02
- Lead Sponsor
- Genoscience Pharma
- Target Recruit Count
- 50
- Registration Number
- NCT03316222
- Locations
- π«π·
Saint-Joseph Hospital, Paris, France
π«π·CHU Grenoble, Grenoble, France
π§πͺJules Bordet Institute, Brussel, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath